We are pleased to announce Perceptive Life Sciences has invested USD 20 million into Anteris
Share
We are pleased to announce Perceptive Life Sciences has invested USD 20 million into Anteris. The funds will help advance the development of DurAVR THV in humans as we bring a valve that lasts longer & works better to patients around the world. https://bit.ly/3l9DcwJ
This website may use cookies to analyze your traffic on this site. Anonymised data from the site may be supplied to social media, advertising and analytics partners who may combine it with other information that you’ve provided or that they’ve collected from your use of their services
